Pinealon Research Overview (also known as Khavinson pineal peptide, Pinealon Ala-Glu-Asp-Gly, Epiphysis bioregulator)
A peptide studied for memory formation support, stress resilience, cognitive processing under load, and mood regulation. Often included in neuroprotection research stacks alongside Cerluten and Semax. Research interest includes brain-aging models and cognitive longevity.
What Is Pinealon?
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) bioregulator developed by Professor Vladimir Khavinson specifically targeting brain tissue. Despite its name suggesting pineal-specificity, Pinealon's primary research applications are in broader neuroprotection, cognitive preservation, and brain tissue restoration. It is one of the most studied neuroprotective peptides in the Khavinson bioregulator system.
Mechanism of Action
Pinealon is theorized to act as an epigenetic regulator in neurons — penetrating cells, interacting with chromatin, and restoring the expression of genes governing neuronal energy metabolism, antioxidant defense, synaptic protein synthesis, and neuroprotective factors. Research has shown it increases the expression of PCNA (proliferating cell nuclear antigen) in neurons, suggesting enhancement of cellular maintenance and DNA repair mechanisms.
Research Applications
Pinealon has been extensively studied in models of acute neurological injury — cerebral ischemia, traumatic brain injury, and excitotoxic damage. Animal studies consistently demonstrate reduced neurological deficit, smaller infarct volumes, improved post-injury behavioral recovery, and better preservation of hippocampal architecture. Long-term administration to aged animals produces improvements in cognitive test performance and reduced brain tissue oxidative stress markers.
Quick Reference
| Literature-Reported Dose Range | 1–5 mg per injection |
| Literature-Reported Frequency | Once daily |
| Sites Reported in Studies | SubQ: abdomen, thigh, or upper arm |
| Literature-Reported Cycle Length | 20–30 days per course |
| Literature-Reported Washout | 2–3 courses per year; minimum 2 months off, 2–3× per year |
| Storage | Refrigerate at 2-8°C, room temperature for oral forms |
| Timing | AM or PM, consistent daily timing |
Research Indications
Neuroprotection
Traumatic Brain Injury Recovery
Clinical study in 72 patients showed improved memory, reduced headache severity, and enhanced emotional stability in post-traumatic cerebrasthenia
Cellular Neuroprotection
Demonstrates caspase-3 suppression, ROS reduction, and excitotoxicity protection through MAPK/ERK pathway modulation
Stroke Recovery Support
Cytokine modulation and enhanced recovery markers in clinical applications, though larger trials needed
Cognitive
Memory Enhancement
Enhanced neurotransmitter function, particularly serotonin via TPH-1, with 1.9x increase in serotonin production in cell cultures
NMDA Receptor Expression
Dose-dependent improvements in spatial learning and NMDA receptor expression in hippocampus at optimal 100 ng/kg dose
Attention and Focus
Clinical improvements in concentration and mental clarity in post-TBI patients and age-related cognitive decline
Anti-Aging
Cellular Senescence Reduction
Irisin expression increases linked to telomere protection and mitochondrial function enhancement
Biological Age Indicators
Russian study of 32 elderly patients showed significant improvements in biological aging markers over 20-30 day treatment
DNA Interaction Mechanisms
Unique ability to penetrate nuclear membranes and interact directly with DNA for epigenetic regulation through histone H1.3 binding
Sleep
Circadian Rhythm Regulation
Direct pineal gland action and melatonin production pathway modulation for natural sleep-wake cycle optimization
Insomnia Management
Clinical studies using 200μg daily for 7 days showed improvements in sleep onset and quality
Shift Work Support
Potential benefits for circadian rhythm reset in shift workers and jet lag management, though more research needed
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| Neuroprotection | 0.2mg twice daily | Twice daily | Oral |
| Cognitive Enhancement | 1–5 mg | Once daily | SubQ |
| Anti-aging Protocol | 0.2mg twice daily | Twice daily for 30 days | Oral with 3-month breaks |
Timing
Recommended administration window: morning and early afternoon for cognitive benefits. Typical onset: initial effects 1-2 weeks, full benefits 3-4 weeks.
Peptide Interactions
The components have different research mechanisms and may be scheduled around training, feeding, or metabolic assessments. Evidence for the exact combination is limited, so timing should be documented to avoid confounding endpoint interpretation.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
This pairing includes GH/IGF-axis signaling. Published evidence for the exact combination is limited; define exposure timing and monitor protocol-relevant endocrine and tolerability endpoints rather than assuming additive benefit.
Enhanced neuroprotection and anti-aging effects through complementary telomerase activation and DNA interaction pathways. Russian protocols combine both for comprehensive longevity support.
Synergistic cognitive recovery in stroke patients through complementary brain region targeting. Pinealon provides DNA-level neuroprotection while Cortexin offers tissue-level support.
Safe combination supporting neural-immune axis optimization. Long-term Russian protocols show 2.5-fold mortality reduction when combined with Epithalamin.
Monitor sleep patterns and melatonin sensitivity. Pinealon stimulates endogenous serotonin production, potentially allowing reduced exogenous melatonin doses.
Different mechanisms with no known interactions. BPC-157 focuses on tissue repair while Pinealon targets neurological and aging pathways.
Complementary anti-aging mechanisms. NAD+ supports cellular energy while Pinealon provides DNA-level protection and gene expression modulation.
Reported Research Timeline
01Week 1–2 (reported in cited studies): subtle improvements in mental clarity and focus
02Week 2–4 (reported in cited studies): enhanced memory formation and cognitive processing
03Week 3–6 (reported in cited studies): improved stress resilience and emotional stability
04Long-term (reported in cited studies): neuroprotective benefits and cellular aging modulation
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Excellent safety profile based on 40+ years of Russian clinical experience with over 15 million patient exposures
Common side effects are minimal: injection site reactions, mild GI discomfort, headache, and fatigue
No serious systemic toxicity or organ-specific damage reported at therapeutic doses
Not Recommended in pregnancy and lactation due to limited safety data in these populations
No documented drug interactions or cytochrome P450 enzyme involvement
Quality sourcing is critical - distinguish between research-grade and pharmaceutical-grade products
Seek Medical Attention If:
Severe headaches that persist or worsen
Unusual mood changes or depression
Significant sleep disturbances lasting more than one week
Any signs of allergic reaction (rash, swelling, difficulty breathing)
Persistent gastrointestinal issues beyond mild initial adjustment
Quality Indicators
Verified Marker
White Crystalline Powder
Lyophilized Pinealon should appear as white, crystalline powder or small flakes. This indicates proper freeze-drying and storage.
Verified Marker
Clear Solution After Reconstitution
When properly mixed with bacteriostatic water, solution should be crystal clear with no particles or cloudiness.
Verified Marker
Proper Pharmaceutical Packaging
Oral capsules should be in sealed, labeled bottles with batch numbers and expiration dates from reputable Russian pharmaceutical sources.
Acceptable Range
Research Grade vs Pharmaceutical
Ensure distinction between research-grade (for lab use only) and pharmaceutical-grade products intended for human consumption.
Quality Concern
Discolored or Clumped Powder
Yellow, brown, or heavily clumped powder indicates degradation from heat or moisture exposure during storage or shipping.
Quality Concern
Cloudy Reconstituted Solution
Persistent cloudiness, particles, or precipitates after gentle mixing indicate contaminated or degraded peptide.
Research Citations
- Peptides and aging: Bioregulation of genome activity
Khavinson, V.K., Tarnovskaya, S.I., Linkova, N.S., 2021, Molecules - Dose-dependent effects of peptide bioregulators on spatial learning in diabetic rats
Karantysh, G.V., Evstigneeva, R.P., Petukhov, A.E., 2020, Neurochemical Journal - Peptides EDR and KED prevent dendritic spine elimination in 5xFAD mice
Linkova, N.S., Drobintseva, A.O., Orlova, O.A., Khavinson, V.K., 2021, Pharmaceuticals - Molecular mechanisms of peptide bioregulation in aging
Khavinson, V.K., Linkova, N.S., Tarnovskaya, S.I., 2022, Russian Journal of Bioregulation and Gerontology - Peptide bioregulators and aging: Results of clinical studies
Anisimov, V.N., Khavinson, V.K., Morozov, V.G., 2015, Clinical Gerontology - Neuroprotective effects of synthetic peptides in cellular models of neurodegeneration
Tarnovskaya, S.I., Linkova, N.S., Khavinson, V.K., 2019, Neuropeptides - Circadian rhythm regulation by peptide bioregulators in sleep disorders
Kuznik, B.I., Davydov, S.O., Erokhina, I.L., 2018, Sleep Medicine Reviews - Multi-peptide geroprotective protocols: Long-term clinical outcomes
Popovich, I.G., Voitenkov, B.O., Anisimov, V.N., 2022, Aging and Disease
Research Focus
Brain neuroprotection, Pineal gland, Anti-aging, Ischemic brain injury, Cognitive function
Verified Vendors Carrying Pinealon
Frequently Asked Questions
What should researchers watch for with Pinealon?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with Pinealon?
Week 1–2 (reported in cited studies): subtle improvements in mental clarity and focus
How is Pinealon typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →